Phase 3 data show Deuruxolitinib significantly improve scalp hair regrowth in Alopecia Areata
The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform
Man Industries (India) Limited has received a new export order of approximately Rs. 1,300 crores.
KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.
The collaboration between both the ministries will play an important role in enhancing the skill and service sector related to Ayurveda
Expands robotics to 20+ specialities
Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
The facility has been set up to manufacture tuberculosis testing cartridges
Proposed combination enhances Pfizer’s position as a leading company in oncology
Subscribe To Our Newsletter & Stay Updated